110 related articles for article (PubMed ID: 27987347)
1. Integrated analysis reveals candidate mRNA and their potential roles in uterine leiomyomas.
Xia L; Liu Y; Fu Y; Dongye S; Wang D
J Obstet Gynaecol Res; 2017 Jan; 43(1):149-156. PubMed ID: 27987347
[TBL] [Abstract][Full Text] [Related]
2. Molecular differential analysis of uterine leiomyomas and leiomyosarcomas through weighted gene network and pathway tracing approaches.
Sahly NN; Banaganapalli B; Sahly AN; Aligiraigri AH; Nasser KK; Shinawi T; Mohammed A; Alamri AS; Bondagji N; Elango R; Shaik NA
Syst Biol Reprod Med; 2021 Jun; 67(3):209-220. PubMed ID: 33685300
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
Ling J; Wu X; Fu Z; Tan J; Xu Q
Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
[TBL] [Abstract][Full Text] [Related]
4. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
Di Tommaso S; Tinelli A; Malvasi A; Massari S
Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
[TBL] [Abstract][Full Text] [Related]
5. Integrative analysis of the DNA methylome and transcriptome in uterine leiomyoma shows altered regulation of genes involved in metabolism, proliferation, extracellular matrix, and vesicles.
Carbajo-García MC; Corachán A; Juárez-Barber E; Monleón J; Payá V; Trelis A; Quiñonero A; Pellicer A; Ferrero H
J Pathol; 2022 Aug; 257(5):663-673. PubMed ID: 35472162
[TBL] [Abstract][Full Text] [Related]
6. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review.
Arslan AA; Gold LI; Mittal K; Suen TC; Belitskaya-Levy I; Tang MS; Toniolo P
Hum Reprod; 2005 Apr; 20(4):852-63. PubMed ID: 15705628
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas.
Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N
PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951
[TBL] [Abstract][Full Text] [Related]
8. H3K4me3 mediates uterine leiomyoma pathogenesis via neuronal processes, synapsis components, proliferation, and Wnt/β-catenin and TGF-β pathways.
Carbajo-García MC; Juarez-Barber E; Segura-Benítez M; Faus A; Trelis A; Monleón J; Carmona-Antoñanzas G; Pellicer A; Flanagan JM; Ferrero H
Reprod Biol Endocrinol; 2023 Jan; 21(1):9. PubMed ID: 36703136
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.
Hodge JC; Kim TM; Dreyfuss JM; Somasundaram P; Christacos NC; Rousselle M; Quade BJ; Park PJ; Stewart EA; Morton CC
Hum Mol Genet; 2012 May; 21(10):2312-29. PubMed ID: 22343407
[TBL] [Abstract][Full Text] [Related]
10. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
[TBL] [Abstract][Full Text] [Related]
11. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids.
Wei T; Geiser AG; Qian HR; Su C; Helvering LM; Kulkarini NH; Shou J; N'Cho M; Bryant HU; Onyia JE
BMC Womens Health; 2007 Apr; 7():5. PubMed ID: 17407572
[TBL] [Abstract][Full Text] [Related]
12. Identification of up-regulated genes in human uterine leiomyoma by suppression subtractive hybridization.
Li B; Zhang YL
Cell Res; 2002 Sep; 12(3-4):215-21. PubMed ID: 12296380
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of early growth response-1 gene in leiomyoma as identified by mRNA differential display.
Pambuccian CA; Oprea GM; Lakatua DJ
Gynecol Oncol; 2002 Mar; 84(3):431-6. PubMed ID: 11855883
[TBL] [Abstract][Full Text] [Related]
14. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
[TBL] [Abstract][Full Text] [Related]
15. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium.
Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J
Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091
[TBL] [Abstract][Full Text] [Related]
16. Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas.
Bondagji NS; Morad FA; Al-Nefaei AA; Khan IA; Elango R; Abdullah LS; M Al-Mansouri N; Sabir J; Banaganapalli B; Edris S; Shaik NA
J Obstet Gynaecol Res; 2017 Feb; 43(2):330-338. PubMed ID: 27987337
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.
Bloch J; Holzmann C; Koczan D; Helmke BM; Bullerdiek J
Oncotarget; 2017 May; 8(21):34762-34772. PubMed ID: 28410233
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of caveolin-1 in human myometrial and uterine leiomyoma smooth muscle.
Zhou Y; Ren Y; Cui L; Li Z; Zhu Y; Lin W; Wang Y
Am J Obstet Gynecol; 2014 Nov; 211(5):496.e1-496.e13. PubMed ID: 24909339
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth.
Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E
Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression in uterine leiomyoma.
Skubitz KM; Skubitz AP
J Lab Clin Med; 2003 May; 141(5):297-308. PubMed ID: 12761473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
